Adenovirus-mediated expression of growth and differentiation factor-5 promotes chondrogenesis of adipose stem cells.

Gang Feng, Yuqing Wan, Gary Balian, Cato T Laurencin, Xudong Li
Author Information
  1. Gang Feng: Department of Orthopaedic Surgery, The Second Clinical Hospital of North Sichuan Medical College, Nanchong 637000, Sichuan Province, People's Republic of China.

Abstract

The repair of articular cartilage injuries is impeded by the avascular and non-innervated nature of cartilage. Transplantation of autologous chondrocytes has a limited ability to augment the repair process due to the highly differentiated state of chondrocytes and the risks of donor-site morbidity. Mesenchymal stem cells can undergo chondrogenesis in the presence of growth factors for cartilage defect repair. Growth and differentiation factor-5 (GDF5) plays an important role in chondrogenesis. In this study, we examined the effects of GDF5 on chondrogenesis of adipose-derived stem cells (ADSCs) and evaluate the chondrogenic potentials of GDF5 genetically engineered ADSCs using an in vitro pellet culture model. Rat ADSCs were grown as pellet cultures and treated with chondrogenic media (CM). Induction of GDF5 by an adenovirus (Ad-GDF5) was compared with exogenous supplementation of GDF5 (100 ng/ml) and transforming growth factor-beta (TGF-beta1; 10 ng/ml). The ADSCs underwent chondrogenic differentiation in response to GDF5 exposure as demonstrated by production of proteoglycan, and up-regulation of collagen II and aggrecan at the protein and mRNA level. The chondrogenic potential of a one-time infection with Ad-GDF5 was weaker than exogenous GDF5, but equal to that of TGF-beta1. Stimulation with growth factors or CM alone induced transient expression of the mRNA for collagen X, indicating a need for optimization of the CM. Our findings indicate that GDF5 is a potent inducer of chondrogenesis in ADSCs, and that ADSCs genetically engineered to express prochondrogenic growth factors, such as GDF5, may be a promising therapeutic cell source for cartilage tissue engineering.

References

  1. Osteoarthritis Cartilage. 2002 May;10(5):394-401 [PMID: 12027540]
  2. Keio J Med. 2005 Sep;54(3):132-41 [PMID: 16237275]
  3. J Orthop Res. 1989;7(2):208-18 [PMID: 2918421]
  4. Biomaterials. 2005 Dec;26(34):7082-94 [PMID: 15985292]
  5. Arthritis Rheum. 2006 Oct;54(10):3254-66 [PMID: 17009260]
  6. Mol Biol Cell. 2002 Dec;13(12):4279-95 [PMID: 12475952]
  7. Biochem Biophys Res Commun. 1994 Oct 28;204(2):646-52 [PMID: 7980526]
  8. Connect Tissue Res. 2006;47(5):264-70 [PMID: 17118748]
  9. J Gene Med. 2006 Jan;8(1):100-11 [PMID: 16097039]
  10. Exp Cell Res. 2001 Aug 15;268(2):189-200 [PMID: 11478845]
  11. Am J Vet Res. 1992 Dec;53(12):2364-70 [PMID: 1476323]
  12. N Engl J Med. 1994 Oct 6;331(14):889-95 [PMID: 8078550]
  13. Tissue Eng. 2006 Jun;12(6):1393-403 [PMID: 16846338]
  14. Arthritis Rheum. 1998 Feb;41(2):263-73 [PMID: 9485084]
  15. J Orthop Res. 2000 Sep;18(5):790-9 [PMID: 11117302]
  16. Tissue Eng. 2001 Apr;7(2):211-28 [PMID: 11304456]
  17. Growth Factors. 2005 Dec;23(4):313-21 [PMID: 16338794]
  18. J Mol Med (Berl). 2004 Feb;82(2):126-34 [PMID: 14669002]
  19. Matrix Biol. 2002 Aug;21(5):449-59 [PMID: 12225810]
  20. J Orthop Res. 2006 Aug;24(8):1791-8 [PMID: 16779832]
  21. Nat Genet. 1996 Mar;12(3):315-7 [PMID: 8589725]
  22. Virchows Arch A Pathol Anat Histol. 1980;389(2):167-87 [PMID: 7456325]
  23. Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4397-402 [PMID: 11917104]
  24. Gene Ther. 2004 Feb;11(4):351-9 [PMID: 14724680]
  25. Surg Technol Int. 2002 Sep;10:255-60 [PMID: 12384889]
  26. Biochimie. 2005 Jan;87(1):125-8 [PMID: 15733747]
  27. J Bone Joint Surg Am. 2001;83-A Suppl 1(Pt 1):S23-30 [PMID: 11263662]
  28. Stem Cells. 2004;22(7):1152-67 [PMID: 15579636]
  29. Med Klin (Munich). 2003 Dec 15;98 Suppl 2:35-40 [PMID: 14992201]
  30. Orv Hetil. 2005 May 29;146(22):1201-8 [PMID: 15997666]
  31. Differentiation. 1990 Jun;43(3):204-11 [PMID: 2387485]
  32. Cell Mol Biol Lett. 2005;10(2):345-62 [PMID: 16010298]
  33. Curr Gene Ther. 2005 Feb;5(1):37-61 [PMID: 15638710]
  34. Exp Hematol. 2005 Aug;33(8):865-72 [PMID: 16038778]
  35. Acta Chir Orthop Traumatol Cech. 2006 Aug;73(4):251-63 [PMID: 17026884]
  36. Biochem Biophys Res Commun. 2003 Feb 7;301(2):338-43 [PMID: 12565865]
  37. Biochem Biophys Res Commun. 2005 Apr 15;329(3):1076-86 [PMID: 15752764]
  38. Bone. 2007 Feb;40(2):374-81 [PMID: 17070126]
  39. Arthritis Res. 2002;4 Suppl 3:S63-8 [PMID: 12110124]
  40. Biochem Biophys Res Commun. 2004 Dec 10;325(2):453-60 [PMID: 15530414]
  41. J Bone Joint Surg Am. 2006 Feb;88(2):303-8 [PMID: 16452741]
  42. J Cell Biochem. 2004 Apr 15;91(6):1204-17 [PMID: 15048875]
  43. Mol Ther. 2005 Aug;12(2):219-28 [PMID: 16043093]

Grants

  1. R03 AR053653/NIAMS NIH HHS
  2. R03 AR053653-01/NIAMS NIH HHS
  3. R03 AR053653-02/NIAMS NIH HHS
  4. R03 AR053653-03/NIAMS NIH HHS

MeSH Term

Adenoviridae
Adipose Tissue
Animals
Bone Morphogenetic Proteins
Cartilage
Cell Culture Techniques
Cell Differentiation
Chondrogenesis
Gene Expression Regulation
Genetic Therapy
Growth Differentiation Factor 5
RNA, Messenger
Rats
Stem Cells
Tissue Engineering
Transforming Growth Factor beta1

Chemicals

Bone Morphogenetic Proteins
Growth Differentiation Factor 5
RNA, Messenger
Transforming Growth Factor beta1

Word Cloud

Created with Highcharts 10.0.0GDF5ADSCschondrogenesisgrowthcartilagechondrogenicrepairstemcellsfactorsdifferentiationCMchondrocytesfactor-5geneticallyengineeredpelletAd-GDF5exogenousng/mlTGF-beta1collagenmRNAexpressionarticularinjuriesimpededavascularnon-innervatednatureTransplantationautologouslimitedabilityaugmentprocessduehighlydifferentiatedstaterisksdonor-sitemorbidityMesenchymalcanundergopresencedefectGrowthplaysimportantrolestudyexaminedeffectsadipose-derivedevaluatepotentialsusingvitroculturemodelRatgrownculturestreatedmediaInductionadenoviruscomparedsupplementation100transformingfactor-beta10underwentresponseexposuredemonstratedproductionproteoglycanup-regulationIIaggrecanproteinlevelpotentialone-timeinfectionweakerequalStimulationaloneinducedtransientXindicatingneedoptimizationfindingsindicatepotentinducerexpressprochondrogenicmaypromisingtherapeuticcellsourcetissueengineeringAdenovirus-mediatedpromotesadipose

Similar Articles

Cited By